Simplify Genomics, Inc., a genomics-technology company, establishes its Scientific Advisory Board with Dr. Richard Cote, Chair of Pathology and Immunology at Washington University. With the addition of Dr. Cote, Simplify Genomics gains deep expertise in clinical pathology and in the biotechnology industry, as both founder and advisor to numerous biotechnology and pharmaceutical companies operating at the interface of technology and clinical practice.